The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure

被引:81
作者
Bech, P [1 ]
机构
[1] Frederiksborg Cent Cty Hosp, Unit WHO Collaborating Ctr Mental Hlth, DK-3400 Hillerod, Denmark
关键词
rating scales; melancholia scale; validity; reliability; acute therapy; long-term therapy;
D O I
10.1034/j.1600-0447.2002.01404.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To evaluate the psychometric properties of the Bech-Rafaelsen Melancholia Scale (MES) by reviewing clinical trials in which it has been used as outcome measure. Method: The psychometric analysis included internal validity (total scores being a sufficient statistic), interobserver reliability, and external validity (responsiveness in short-term trials and relapse prevention in long-term trials). Results: The results showed that the MES is a unidimensional scale, indicating that the total score is a sufficient statistic. The interobserver reliability of the MES has been found adequate both in unipolar and bipolar depression. External validity including both relapse, response and recurrence indicated that the MES has a high responsiveness and sensitivity. Conclusion: The MES has been found a valid and reliable scale for the measurement of changes in depressive states during short-term as well as long-term treatment.
引用
收藏
页码:252 / 264
页数:13
相关论文
共 99 条
[1]  
ALLERUP P, 1986, STAT ANAL RATING SCA
[2]  
AM J, 1998, PHARMACOPSYCHIATRY, V73, P393
[3]  
American Psychiatric Association, 2000, Diagnostic and statistical manual of mental disorders, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]
[4]  
American Psychiatric Association American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, P947, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596, 10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596.744053]
[5]  
Andersen B, 1990, J AFFECT DISORDERS, V18, P289
[6]  
Anderson I M, 1998, Depress Anxiety, V7 Suppl 1, P11, DOI 10.1002/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.3.CO
[7]  
2-O
[8]  
ANDERSON IM, 1986, PSYCHOPHARMACOLOGY, V89, P131
[9]   THE EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN DEPRESSION - A METAANALYSIS OF STUDIES AGAINST TRICYCLIC ANTIDEPRESSANTS [J].
ANDERSON, IM ;
TOMENSON, BM .
JOURNAL OF PSYCHOPHARMACOLOGY, 1994, 8 (04) :238-249
[10]  
Angst J, 2001, MIL DRUG TH, P21